RxDoctor Payments Data

Patricia Bernard

Family · Orlando, FLNPI 1285278523

Payments from drug & device makers

$522in general payments, 2019–2025

Across 28 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$157
  • Novo Nordisk$94
  • AstraZeneca$78
  • Boehringer Ingelheim$67
  • Lundbeck LLC$26
  • Bayer$21
  • plus $78 from 5 others

What the payments were for

  • Food & beverage$522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$522 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$11,922
Medicare patients
87
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$29,646
EliquisApixaban27$26,737
TrulicityDulaglutide12$24,534
OzempicSemaglutide16$18,354
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,222
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,233
Albuterol Sulfate HfaAlbuterol Sulfate72$1,820
Gabapentin105$1,608
PaxlovidNirmatrelvir/Ritonavir13$1,429
Bupropion XlBupropion Hcl11$918
Levothyroxine Sodium91$882
Atorvastatin Calcium108$779
Fluticasone Propionate60$666
Trazodone Hcl45$634
Pregabalin19$612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$67$29,64626 claims
PfizerEliquis, Paxlovid$15$28,16740 claims
Lilly USA, LLCTrulicity$157$24,53412 claims
Novo NordiskOzempic$94$18,35416 claims
GSKTrelegy Ellipta$16$9,22215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →